D06AX04 neomycin
DERMATOLOGICALS ›ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE ›ANTIBIOTICS FOR TOPICAL USE ›Other antibiotics for topical use
健保收載品項 TFDA 在效許可證 12 FDA 已核准
台灣藥品與外觀
健保收載品名："井田"消疤痕乳膏、"明德" 美疤痕軟膏、"紐約" 新黴素軟膏、〝生化〞欣黴素藥膏、使皮新軟膏、利膚外傷軟膏、去疤乳膏、吉適膚癒乳膏、抗疤消炎乳膏－恩、新黴素軟膏、法蘭西丁－Ｔ粉末、益疤寧軟膏、速備粉
資料來源：食藥署「西藥許可證」＋「藥品 ATC 碼」＋「藥品外觀」＋「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。
適應症
台灣 TFDA 核准適應症
- 膣炎、傳染性膿皮症、膿瘍、癤、疔、瘭疽、腋臭、外傷、火傷、皮膚移植後感染。
- 外傷傷口、手術時的傷口、燒傷、廔管性骨炎、潰瘍性靜脈曲張、動脈潰瘍、疤痕、潰瘍性褥瘡及預防燙傷癒合後引起的皮膚萎縮及瘢瘤。
- 外傷傷口、手術時的傷口、燒傷、瘻管性骨炎、潰瘍性靜脈曲張、動脈潰瘍、疤痕、潰瘍性褥瘡及預防燙傷癒合後引起的皮膚萎縮及瘢瘤。
- 緊急處理、預防因皮膚外傷(如刀傷、擦傷、刺傷、抓傷、磨傷、輕微燙傷)造成的感染或減緩傷口的感染。
- 燙傷、疤痕、瘻管性骨炎、潰瘍性褥瘡及靜脈曲張、預防外傷及手術後傷口癒合引起之皮膚萎縮及瘢瘤。
- 傳染性膿癢症、濕疹性皮膚炎、天?瘡、膿性毛囊炎、鬚瘡。
美國 FDA 適應症（英文原文對照）
INDICATIONS AND USAGE For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococcus aureus, Escherichia coli, Haemophilus influenzae , Klebsiella /Enterobacter species, Neisseria species, and Pseudomonas aeruginosa . This product does not provide adequate coverage against: Serratia marcescens and S treptococci , including Streptococcus pneumoniae .
資料來源：食藥署西藥許可證適應症（中文）、openFDA US SPL（英文，僅供對照）。
健保給付規定
查無健保特殊給付規定條款；本藥品依一般健保藥品支付規定給付。
實證補充
本藥品尚無實證補充整理（未來新增 Review／指引知識時補列）。
台灣藥品與適應症：食藥署西藥許可證＋ATC＋外觀＋仿單開放資料 · FDA：openFDA US SPL · 健保給付：健保署「全民健康保險藥品給付規定」（更新日 2026-06-09）· 實證補充：人工彙整。 本頁為資訊整理，實際給付與適應症以主管機關公告為準。